MacroGenics Chief Medical Officer Stephen Eck to Depart End of 2025

Stephen Eck, M.D., Ph.D., will depart from his role as Senior Vice President, Clinical Development and Chief Medical Officer of MacroGenics, Inc., effective December 31, 2025. Oversight of clinical development will be taken over on an interim basis by Frank Perabo, M.D., Ph.D., Vice President, Clinical Development, while the company searches for a new Chief Medical Officer. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. MacroGenics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001125345-25-000111), on November 20, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT) Original Document: here